RxSight, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | $24.4M | $-430.6M | $14.0M |
| FY2021 | $39.8M | $138.2M | $24.4M |
| FY2022 | $40.2M | $89.9M | $11.8M |
| FY2023 | $0 | $160.4M | $9.7M |
| FY2024 | — | $281.2M | $16.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | $24.4M | $-430.6M | $14.0M |
| FY2021 | $39.8M | $138.2M | $24.4M |
| FY2022 | $40.2M | $89.9M | $11.8M |
| FY2023 | $0 | $160.4M | $9.7M |
| FY2024 | — | $281.2M | $16.7M |